A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

ClinicalTrials.gov ID: NCT07288567

Public ClinicalTrials.gov record NCT07288567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 2:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)

Study identification

NCT ID: NCT07288567
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 166 participants

Conditions and interventions

Conditions

Schizophrenia

Interventions

KarXT Drug
KarXT Matching Placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 13 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 28, 2026
Primary completion: Dec 17, 2029
Completion: Dec 17, 2029
Last update posted: May 10, 2026

2026 – 2029

United States locations

U.S. sites: 19
U.S. states: 11
U.S. cities: 19

Facility	City	State	ZIP	Site status
Local Institution - 0077	Anaheim	California	92805	Not yet recruiting
Inland Psychiatric Medical Group.	Chino	California	91710	Recruiting
Local Institution - 0024	Culver City	California	90230	Not yet recruiting
Local Institution - 0083	Redlands	California	92373	Not yet recruiting
Local Institution - 0089	San Francisco	California	94158	Not yet recruiting
Apg Research, Llc	Orlando	Florida	32803	Recruiting
Atlanta Center for Medical Research	Atlanta	Georgia	30331	Recruiting
Salveo Integrative Health - Lawrenceville	Lawrenceville	Georgia	30046	Recruiting
Local Institution - 0039	Stone Mountain	Georgia	30083	Not yet recruiting
EmVenio Research Center - Prime Healthcare	Chicago	Illinois	60622	Recruiting
Local Institution - 0076	Boston	Massachusetts	02115	Not yet recruiting
Local Institution - 0059	Worcester	Massachusetts	01608	Not yet recruiting
Local Institution - 0061	Great Neck	New York	11021	Not yet recruiting
University of Cincinnati Dept of Psychiatry and Behavioral Neuroscience	Cincinnati	Ohio	45219	Recruiting
Local Institution - 0099	Philadelphia	Pennsylvania	19139	Not yet recruiting
Local Institution - 0113	Nashville	Tennessee	37212	Not yet recruiting
Local Institution - 0046	Garland	Texas	75043	Not yet recruiting
Local Institution - 0066	Spring	Texas	77381	Not yet recruiting
Local Institution - 0050	Richmond	Virginia	23284	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07288567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 10, 2026 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07288567 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →